Skip Navigation



Hum. Reprod. Advance Access published online on April 22, 2004
Human Reproduction, doi:10.1093/humrep/deh169
© 2004 by European Society of Human Reproduction and Embryology
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/6/1357    most recent
deh169v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fasouliotis, S.J.
Right arrow Articles by Rosenwaks, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fasouliotis, S.J.
Right arrow Articles by Rosenwaks, Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received November 28, 2003
Accepted January 8, 2004

Article

Maternal serum levels of interferon-{gamma} and interleukin-2 soluble receptor-{alpha} predict the outcome of early IVF pregnancies

S.J. Fasouliotis 1, S.D. Spandorfer 1*, S.S. Witkin 1, G. Schattman 1, H.C. Liu 1, J.E. Roberts 1, Z. Rosenwaks 1

1 Center for Reproductive Medicine and Infertility, Weill Medical College of Cornell University, New York, NY 10021, USA

* To whom correspondence should be addressed. E-mail: sdspando{at}med.cornell.edu.


  Abstract

BACKGROUND: Elevated maternal serum levels of interleukin-2 soluble receptor-{alpha} (IL-2 sR{alpha}), tumour necrosis factor-{alpha} (TNF-{alpha}) and interferon-{gamma} (IFN-{gamma}) have been associated with pregnancy loss. The aim of our study was to evaluate the predictive value of these cytokines in the outcome of early IVF pregnancies. METHODS: One hundred and fifty-nine consecutive IVF patients who were subsequently diagnosed to have a biochemical pregnancy (n = 23), a first-trimester miscarriage (n = 19) or a normal term delivery (n = 117) were included in this study. Serum was collected from the initial pregnancy test, 11 days after a day 3 embryo transfer, and all samples were analysed for IL-2 sR{alpha}, TNF-{alpha} and IFN-{gamma} by commercially available enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: IL-2 sR{alpha} levels were significantly higher in patients with an early pregnancy loss compared with patients with a normal term delivery (849.5 ± 69.6 versus 693.5 ± 31.2 pg/ml, P = 0.02), and a cut-off point of IL-2 sR{alpha} >1000 pg/ml predicted a poor pregnancy outcome (44.4 versus 22.7% pregnancy loss, IL-2 sR{alpha} >=1000 versus IL-2 sR{alpha} <1000 pg/ml; P = 0.02). IFN-{gamma}-positive patients had twice the risk for poor IVF pregnancy outcome compared with IFN-{gamma}-negative subjects (40.8 versus 20.0%, respectively; P < 0.02), including a significantly lower implantation rate (37.6 ± 0.05 versus 50.0 ± 0.03%, respectively; P = 0.02). There was no difference in pregnancy outcome based upon serum levels, or the ability to detect the presence of TNF-{alpha}. No differences in levels of these cytokines were found based on the aetiology of the patients’ infertility. CONCLUSIONS: Elevated maternal serum levels of IL-2 sR{alpha} and IFN-{gamma} as early as 11 days after embryo transfer are associated with poor IVF pregnancy outcome.

Key words: Key words: IFN-{gamma}/IL-2 sR{alpha}/IVF/pregnancy outcome/TNF-{alpha}


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. Vidal, J. Roa, L. Pinilla, A. Pellicer, and M. Tena-Sempere
Maternal serum ghrelin levels in early IVF pregnancies: lack of prognostic value for viable pregnancy and altered post-prandial responses
Hum. Reprod., April 1, 2008; 23(4): 958 - 963.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.